TJ08
TJ08 is a 1,2,5-trisubstituted benzimidazole compound demonstrating anticancer activity. It functions by inducing G1/S phase cell cycle arrest and promoting apoptosis in various cancer cell lines. Its mechanism and efficacy have been investigated in both in vitro and in vivo preclinical studies.
Product Specifications
CAS Number
2924274-19-9
Product Name Alternative
Apoptosis
Field of Research
Cell Biology
Purity
99.41% (May vary between batches)
Smiles
O=C (C1=CC=C2C (N=C (N2CC3=CC=CC=C3) C4=CC ([N+] ([O-]) =O) =C (F) C=C4) =C1) OC
Molecular Formula
C22H16FN3O4
Molecular Weight
405.38
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A05090-1-APC 100 µg/Vial
Anti-Scavenging Receptor SRB2/SCARB2 Antibody Picoband®, APC Conjugate
Sign In for Pricing
View Details 
H5110-08K3 50 µg
Histone H2A (Histone H2A Type 1-A, Histone H2A/r, H2AFR, Histone Cluster 1 H2aa, HIST1H2AA, bA317E16.2) discontinued
Sign In for Pricing
View Details 130921-ML490 100 µL
PBX2 (G17, Pre-B Cell Leukemia Transcription Factor 2, Homeobox Protein PBX2, Protein G17) (MaxLight 490)
Sign In for Pricing
View Details